Krebs von den Lungen

LDT

Commander ce test

ANTIGÈNES / BIOMARQUEURS

KL-6

SKU / CODE DE TEST

KL6

PROCÉDURE / TECHNIQUE

-

GAMME DE RÉFÉRENCE

-

SENSIBILITÉ / SPÉCIFICITÉ

-

LES ASSOCIATIONS CLINIQUES

Krebs von den Lungen-6 (KL-6) reflects the formation of fibrotic lung disease and is a biomarker used to characterize the risk and severity of interstitial lung diseases (ILDs). KL-6 is also a prognostic biomarker in patients with surgically resected non-small cell lung cancer.

Commander

Autres tests à envisager